Afshar Saber, Wardiya
Sahin, Mustafa https://orcid.org/0000-0001-7044-2953
Funding for this research was provided by:
National Institutes of Health (R01-NS113591, U54-HD090255)
Article History
Received: 30 October 2019
Accepted: 3 February 2020
First Online: 19 February 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: Mustafa Sahin has received research funding from Roche, Novartis, Pfizer, LAM Therapeutics, and Quadrant Biosciences and has served on the Scientific Advisory Board of Sage Therapeutics, Roche, Takeda, and PTEN Research Foundation.